ERBB2 and cancer: It is known that inhibition of EGFR and HER2 activation significantly affects redox regulation mechanisms in cancer cells (Chang et al., 2011; Rodriguez-Hernandez et al., 2020) and may lead to mitochondrial dysfunction.